Security key
640979100
Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA)
CUSIP: 640979100
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 186,788,806
- Total 13F shares
- 52,696,596
- Share change
- +8,948,708
- Total reported value
- $725,374,900
- Put/Call ratio
- 582%
- Price per share
- $13.75
- Number of holders
- 86
- Value change
- +$114,726,209
- Number of buys
- 52
- Number of sells
- 27
Report period
Q1 2024
Institutions
86
Top holders
10
NMRA full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Neumora Therapeutics, Inc. SEC filings
Neumora Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640979100
Recent filing periods:
Top shareholders of NMRA - Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SOFTBANK GROUP CORP. |
13F
|
Company |
4.1%
|
7,646,916
|
$130,379,918 | — | 31 Dec 2023 | |
| FMR LLC |
13F
3/4/5
|
Company · Other* |
3.4%
|
6,373,129
|
$108,661,850 | — | 31 Dec 2023 | |
| MIC Capital Management UK LLP |
13F
|
Company |
2.4%
|
4,460,700
|
$76,054,936 | — | 31 Dec 2023 | |
| ICONIQ Capital, LLC |
13F
|
Company |
1.8%
|
3,398,628
|
$57,946,607 | — | 31 Dec 2023 | |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST |
13F
|
Company |
1.8%
|
3,309,123
|
$56,420,547 | — | 31 Dec 2023 | |
| Artal Group S.A. |
13F
|
Company |
1.4%
|
2,552,702
|
$43,524,000 | — | 31 Dec 2023 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.1%
|
2,071,450
|
$35,318,223 | — | 31 Dec 2023 | |
| Avidity Partners Management LP |
13F
|
Company |
1.1%
|
1,990,632
|
$33,940,276 | — | 31 Dec 2023 | |
| JOHNSON & JOHNSON |
13F
|
Company |
0.99%
|
1,849,445
|
$31,533,037 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.99%
|
1,843,291
|
$30,341,611 | — | 31 Dec 2023 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
0.91%
|
1,699,313
|
$28,973,287 | — | 31 Dec 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.8%
|
1,500,000
|
$25,575,000 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.56%
|
1,044,004
|
$17,800,269 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.32%
|
592,422
|
$10,100,795 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
436,877
|
$7,449,561 | — | 31 Dec 2023 | |
| Alphabet Inc. |
13F
|
Company |
0.22%
|
404,732
|
$6,900,681 | — | 31 Dec 2023 | |
| Logos Global Management LP |
13F
|
Company |
0.2%
|
382,345
|
$6,518,982 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.2%
|
380,954
|
$6,495,266 | — | 31 Dec 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.14%
|
263,000
|
$4,484,150 | — | 31 Dec 2023 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.08%
|
150,000
|
$2,557,500 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
141,478
|
$2,412,200 | — | 31 Dec 2023 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.08%
|
140,666
|
$2,398,355 | — | 31 Dec 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
129,912
|
$2,215,000 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
126,444
|
$2,155,870 | — | 31 Dec 2023 | |
| SCOGGIN MANAGEMENT LP |
13F
|
Company |
0.07%
|
125,000
|
$2,131,250 | — | 31 Dec 2023 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.06%
|
105,990
|
$1,807,130 | — | 31 Dec 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.05%
|
92,293
|
$1,573,596 | — | 31 Dec 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
89,339
|
$1,523,230 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
61,117
|
$1,042,045 | — | 31 Dec 2023 | |
| NORGES BANK |
13F
|
Company |
0.03%
|
50,000
|
$852,500 | — | 31 Dec 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.03%
|
46,883
|
$799,000 | — | 31 Dec 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
45,200
|
$770,660 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
31,079
|
$529,897 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
27,355
|
$466,403 | — | 31 Dec 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.01%
|
20,749
|
$353,770 | — | 31 Dec 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
20,539
|
$350,190 | — | 31 Dec 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
15,720
|
$268,019 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
15,120
|
$257,797 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
13,600
|
$232,000 | — | 31 Dec 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
11,327
|
$193,125 | — | 31 Dec 2023 | |
| Ghisallo Capital Management LLC |
13F
|
Company |
0.01%
|
10,000
|
$170,500 | — | 31 Dec 2023 | |
| Legacy Private Trust Co. |
13F
|
Company |
0.01%
|
10,000
|
$170,500 | — | 31 Dec 2023 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0%
|
8,487
|
$144,703 | — | 31 Dec 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
8,007
|
$136,519 | — | 31 Dec 2023 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
7,394
|
$126,068 | — | 31 Dec 2023 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
6,900
|
$117,645 | — | 31 Dec 2023 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0%
|
6,328
|
$107,892 | — | 31 Dec 2023 | |
| SG Americas Securities, LLC |
13F
|
Company |
0%
|
6,308
|
$108,000 | — | 31 Dec 2023 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
5,746
|
$97,969 | — | 31 Dec 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
4,939
|
$84,000 | — | 31 Dec 2023 |
Institutional Holders of Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA) as of Q1 2024
As of 31 Mar 2024,
Neumora Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NMRA) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,696,596 shares.
The largest 10 holders included
SOFTBANK GROUP CORP., FMR LLC, MIC Capital Management UK LLP, T. Rowe Price Investment Management, Inc., ICONIQ Capital, LLC, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, Artal Group S.A., EcoR1 Capital, LLC, JOHNSON & JOHNSON, and CITADEL ADVISORS LLC.
This page lists
86
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
60
Q1 2024 holders
86
Holder diff
26
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.